EE232 Impact of Updated Mortality Estimates on the Cost-Effectiveness of Rifaximin for the Treatment of Patients with Overt Hepatic Encephalopathy
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.533
https://www.valueinhealthjournal.com/article/S1098-3015(23)00633-2/fulltext
Title :
EE232 Impact of Updated Mortality Estimates on the Cost-Effectiveness of Rifaximin for the Treatment of Patients with Overt Hepatic Encephalopathy
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)00633-2&doi=10.1016/j.jval.2023.03.533
First page :
Section Title :
Open access? :
No
Section Order :
10019